Remove Doctors Remove Medical Schools Remove Molecular Biology
article thumbnail

Advancements in upstream CLD for enhanced biotherapeutics production

Drug Discovery World

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School and a PhD in Virology/Molecular Biology. The post Advancements in upstream CLD for enhanced biotherapeutics production appeared first on Drug Discovery World (DDW).

article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

Dr Alani also directs a clinical program at Boston Medical Center focused on patients with melanoma and other high-risk skin cancers and has been recognized as a 2024 Boston Magazine and Castle Connolly Top Doctor. Dr Alani received her M.D. degree with Honors and Distinction in Research from the University of Michigan.

article thumbnail

Battling antibiotic resistance in the lab and the clinic

Broad Institute

Patients with possible undiagnosed infections kept him up at night as he ran through their medical histories, occupations, and personal life details in his mind, searching for clues to the identity of the microscopic invaders. A combined MD/PhD program offered both opportunities.

Hospitals 137